Evolent Health (EVH) Cash & Current Investments (2015 - 2026)

Evolent Health's Cash & Current Investments history runs 12 years deep, the most recent figure standing at $166.0 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 36.84% year-over-year to $166.0 million; the TTM figure through Mar 2026 stood at $166.0 million (down 36.84% YoY), while the FY2025 annual figure was $178.0 million, up 8.86% from the prior year.
• Cash & Current Investments was $166.0 million for Q1 2026 at Evolent Health, down from $178.0 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $267.4 million in Q2 2022 to a low of $112.9 million in Q3 2024.
• Historically, Cash & Current Investments has averaged $189.6 million across 5 years, with a median of $181.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 45.64% in 2024, then surged 44.57% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $202.7 million in 2022, then climbed by 1.92% to $206.6 million in 2023, then declined by 20.86% to $163.5 million in 2024, then increased by 8.86% to $178.0 million in 2025, then fell by 6.75% to $166.0 million in 2026.
• The last three Cash & Current Investments figures came in at $166.0 million (Q1 2026), $178.0 million (Q4 2025), and $140.3 million (Q3 2025), per Business Quant data.